TEK (Amgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTEK (Amgen)
Drug Alias NameTek-IgG fusion protein (Immunex)ORK (Immunex)TWEAKR (Immunex)Tek(delta)-Fctunica interna endothelial cell kinase (Amgen) +[8] 
ClassificationBiologics > Protein drugs > EnzymeBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTEK receptor tyrosine kinase modulators
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsRetinal DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncImmunex Corp
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A